TNFRSF1B and hematopoietic and lymphoid cell neoplasm: This finding is not surprising considering the fact that activation of TNFRII triggers pro-survival signaling in hematological cancer cells [22], and activation of TNFRI is required for any death signaling from TNFRII due to the lack of a death domain in TNFRII [27].